Chlamydia Pneumoniae Infection in Patients with Lung Cancer and Chronic Obstructive Pulmonary Disease

张梅春,陈琼,胡成平,贺铁生
DOI: https://doi.org/10.3969/j.issn.1005-8982.2004.14.008
2004-01-01
Abstract:Objective: To investigate the presence of chlamydia pneumoniae (Cpn) infection in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) and lung cancer. Methods: Serum IgM and IgG antibodies for Chlamydia pneumoniae in patients, in which 126 and 128 cases were COPD and lung cancer group respectively, were measured by enzyme-linked immunosorbant assays. The 70 samples of the healthy control group were selected from the healthy outpatients during physical examinations. Results:The positive ratio of serologic IgM antibodies for Cpn in group COPD was up to 36.5% (46/126) which was much higher than that in group lung cancer (21.8%, 28/128) and that in the control (1.4%, 1/70). The difference was statistically significant (P <0.005), respectively . And the ratio of group lung cancer was the same statistically significant difference (P <0.005). While the positive ratio of serologic IgG antibodies in either group COPD or group lung cancer was no statistical significance, compared with the control. But the positive ratio of IgM and /or IgG antibodies of group COPD and group lung cancer were 32.8% (42/126) and 23.1%(30/128), respectively. which had the significant differences, compared with the control. And the total-positive ratio of all the samples reached 22.8% (74/324). Conclusion: It shows that patients with lung cancer accompanied by pulmonary infection and acute exacerbation of chronic obstructive pulmonary disease are all liable to the infection of chlamydia pneumoniae, of which the clinical presentation is acute infection. And Cpn may be the main pathogenic microbes of those patients and so Cpn infection should be considered for patients with lung cancer companied with pulmonary infection and acute exacerbation of COPD.
What problem does this paper attempt to address?